Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Ivers-Read Gillian C converted options into 20,938 shares and sold $20,097 worth of shares (10,770 units at $1.87), increasing direct ownership by 4% to 274,142 units (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.